Bestdoc Technology Profile
Key Indicators
- Authorised Capital ₹ 1.42 M
as on 16-06-2024
- Paid Up Capital ₹ 0.56 M
as on 16-06-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 24.00%
(FY 2023)
- Profit 14.77%
(FY 2023)
- Ebitda 25.82%
(FY 2023)
- Net Worth -88.11%
(FY 2023)
- Total Assets -68.50%
(FY 2023)
About Bestdoc Technology
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.42 M and a paid-up capital of Rs 0.56 M, as per Ministry of Corporate Affairs (MCA) records.
Soudabi Neduvanchery, Fayaz Abdu, and Afsal Salu serve as directors at the Company.
- CIN/LLPIN
U74999KL2016PTC046000
- Company No.
046000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kochi, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bestdoc Technology?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Afsal Salu | Managing Director | 29-Dec-2017 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Soudabi Neduvanchery | Director | 14-Jun-2016 | Current |
Fayaz Abdu | Director | 14-Jun-2016 | Current |
Financial Performance and Corporate Structure Insights of Bestdoc Technology.
Bestdoc Technology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24% increase. The company also saw a substantial improvement in profitability, with a 14.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 88.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bestdoc Technology?
In 2023, Bestdoc Technology had a promoter holding of 95.32% and a public holding of 4.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medisuite Life Science Private Limited
Active 2 years 3 monthsSoudabi Neduvanchery is a mutual person
Exuberant Services And Solutions Private Limited
Active 12 years 10 monthsFayaz Abdu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bestdoc Technology?
Bestdoc Technology has a workforce of 20 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bestdoc Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bestdoc Technology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.